Abstract
Preclinical research on neuroendocrine tumors usually involves immortalized cell lines and few animal models. In the present study we described an in vivo model based on patient-derived xenografts of neuroendocrine tumor cells in zebrafish (Danio rerio) embryos, allowing a rapid analysis of the angiogenic and invasive potential. Patient-derived neuroendocrine tumor cells were transplanted in 48 hours post-fertilization Tg(fli1a:EGFP) y1 zebrafish embryos that express enhanced green fluorescent protein in the entire vasculature. Neuroendocrine tumor cells, stained with CM-Dil, were injected into the subperidermal (perivitelline) space, close to the developing subintestinal venous plexus. A proper control group, represented by zebrafish injected with only D-PBS, was included in this study. Angiogenic and invasive potentials of each patient-derived xenograft were evaluated by both epifluorescence and confocal microscopes. Six out of eight neuroendocrine tumor samples were successfully transplanted in zebrafish embryos. Although the implanted tumor mass had a limited size (about 100 cells for embryos), patient-derived xenografts showed pro-angiogenic (5 cases) and invasive (6 cases) behaviors within 48 hours post injection. Patient-derived xenograft in zebrafish embryos appears to be a reliable in vivo preclinical model for neuroendocrine tumors, tumors with often limited cell availability. The rapidity of this procedure makes our model a promising platform to perform preclinical drug screening and opens a new scenario for personalized treatment in patients with neuroendocrine tumors.
Similar content being viewed by others
References
K.I. Alexandraki, G. Kaltsas, Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy. Endocrine 41(1), 40–52 (2012). doi:10.1007/s12020-011-9562-2
F. Grillo, M. Albertelli, F. Annunziata, M. Boschetti, A. Caff, S. Pigozzi, D. Ferone, L. Mastracci: Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible? Endocrine (2015). doi:10.1007/s12020-015-0734-310.1007/s12020-015-0734-3
A. Walenkamp, G. Crespo, F. Fierro Maya, R. Fossmark, P. Igaz, A. Rinke, G. Tamagno, G. Vitale, K. Oberg, T. Meyer, Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment. Endocr. Relat. Cancer 21(6), R445–R460 (2014). doi:10.1530/ERC-14-0106ERC-14-0106
V. Babu, N. Paul, R. Yu, Animal models and cell lines of pancreatic neuroendocrine tumors. Pancreas 42(6), 912–923 (2013). doi:10.1097/MPA.0b013e31827ae99300006676-201308000-00003
K.E. Lines, M. Stevenson, R.V. Thakker, Animal models of pituitary neoplasia. Mol. Cell. Endocrinol. 421, 68–81 (2016). doi:10.1016/j.mce.2015.08.024S0303-7207(15)30064-2
T. Wiedemann, N.S. Pellegata, Animal models of multiple endocrine neoplasia. Mol. Cell. Endocrinol. 421, 49–59 (2016). doi:10.1016/j.mce.2015.07.004S0303-7207(15)30013-7
R. White, K. Rose, L. Zon, Zebrafish cancer: the state of the art and the path forward. Nat. Rev. Cancer 13(9), 624–636 (2013). doi:10.1038/nrc3589nrc3589
G. Vitale, G. Gaudenzi, A. Dicitore, F. Cotelli, D. Ferone, L. Persani, Zebrafish as an innovative model for neuroendocrine tumors. Endocr. Relat. Cancer 21(1), R67–R83 (2014). doi:10.1530/ERC-13-0388ERC-13-0388
N.D. Lawson, B.M. Weinstein, In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248(2), 307–318 (2002). doi:S0012160602907116
S.Y. Choi, D. Lin, P.W. Gout, C.C. Collins, Y. Xu, Y. Wang, Lessons from patient-derived xenografts for better in vitro modeling of human cancer. Adv. Drug Deliv. Rev. 79–80, 222–237 (2014). doi:10.1016/j.addr.2014.09.009S0169-409X(14)00207-5
J.W. Cassidy, C. Caldas, A. Bruna, Maintaining Tumor heterogeneity in patient-derived tumor xenografts. Cancer Res. 75(15), 2963–2968 (2015). doi:10.1158/0008-5472.CAN-15-07270008-5472.CAN-15-0727
C.B. Kimmel, W.W. Ballard, S.R. Kimmel, B. Ullmann, T.F. Schilling, Stages of embryonic development of the zebrafish. Dev. Dyn. 203(3), 253–310 (1995). doi:10.1002/aja.1002030302
T. Florio, F. Barbieri, R. Spaziante, G. Zona, L.J. Hofland, P.M. van Koetsveld, R.A. Feelders, G.K. Stalla, M. Theodoropoulou, M.D. Culler, J. Dong, J.E. Taylor, J.P. Moreau, A. Saveanu, G. Gunz, H. Dufour, P. Jaquet, Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study. Endocr. Relat. Cancer 15(2), 583–596 (2008). doi:10.1677/ERC-07-027115/2/583
A. Mohamed, M.P. Blanchard, M. Albertelli, F. Barbieri, T. Brue, P. Niccoli, J.R. Delpero, G. Monges, S. Garcia, D. Ferone, T. Florio, A. Enjalbert, V. Moutardier, A. Schonbrunn, C. Gerard, A. Barlier, A. Saveanu, Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures. Endocr. Relat. Cancer 21(5), 691–704 (2014). doi:10.1530/ERC-14-0086ERC-14-0086
S. Nicoli, M. Presta, The zebrafish/tumor xenograft angiogenesis assay. Nat. Protoc. 2(11), 2918–2923 (2007). doi:nprot.2007.412 [pii]10.1038/nprot.2007.412
M. Schartl, Beyond the zebrafish: diverse fish species for modeling human disease. Dis. Model. Mech. 7(2), 181–192 (2014). doi:10.1242/dmm.012245dmm.012245
J. Wertman, C.J. Veinotte, G. Dellaire, J.N. Berman, The zebrafish xenograft platform: evolution of a novel cancer model and preclinical screening tool. Adv. Exp. Med. Biol. 916, 289–314 (2016). doi:10.1007/978-3-319-30654-4_13
I.J. Marques, F.U. Weiss, D.H. Vlecken, C. Nitsche, J. Bakkers, A.K. Lagendijk, L.I. Partecke, C.D. Heidecke, M.M. Lerch, C.P. Bagowski, Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 9, 128 (2009). doi:10.1186/1471-2407-9-1281471-2407-9-128
C.J. Veinotte, G. Dellaire, J.N. Berman, Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era. Dis. Model. Mech. 7(7), 745–754 (2014). doi:10.1242/dmm.0157847/7/745
J. Barriuso, R. Nagaraju, A. Hurlstone, Zebrafish: a new companion for translational research in oncology. Clin. Cancer Res. 21(5), 969–975 (2015). doi:10.1158/1078-0432.CCR-14-29211078-0432.CCR-14-2921
M. Konantz, T.B. Balci, U.F. Hartwig, G. Dellaire, M.C. Andre, J.N. Berman, C. Lengerke, Zebrafish xenografts as a tool for in vivo studies on human cancer. Ann. N. Y. Acad. Sci. 1266, 124–137 (2012). doi:10.1111/j.1749-6632.2012.06575.x
C.L. Morton, P.J. Houghton, Establishment of human tumor xenografts in immunodeficient mice. Nat. Protoc. 2(2), 247–250 (2007). doi:nprot.2007.25 [pii]10.1038/nprot.2007.25
M.J. Puchner, D.K. Ludecke, W. Saeger, H.D. Herrmann, Use of athymic nude mice for in vivo studies of human growth-hormone-secreting pituitary adenomas. Horm. Res. 35(5), 198–204 (1991)
J.H. Yang, J. Hu, L. Wan, L.J. Chen, Barbigerone inhibits tumor angiogenesis, growth and metastasis in melanoma. Asian Pac. J. Cancer Prev. 15(1), 167–174 (2014)
C. Zhao, X. Wang, Y. Zhao, Z. Li, S. Lin, Y. Wei, H. Yang, A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors. PLoS One 6(7), e21768 (2011). doi:10.1371/journal.pone.0021768PONE-D-11-08517
Acknowledgments
This work was partially supported by the Italian Ministry of Education, Research and University (FIRB RBAP11884M).
Author information
Authors and Affiliations
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Gaudenzi, G., Albertelli, M., Dicitore, A. et al. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors. Endocrine 57, 214–219 (2017). https://doi.org/10.1007/s12020-016-1048-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1048-9